Posted in | News | Sustainability | Energy

Topsoe Updates Financial Outlook for 2026

Based on strong execution within our Technology business, and an improved outlook for catalyst sales for the second half of 2026, the full year guidance on revenue and earnings margin is adjusted.

The full year outlook for 2026 for revenue is revised to DKK 8,000–8,500 million (previous range DKK 7,600–8,400 million). EBIT before special items margin is revised to 7.0–10.0% (previous range 4.0–9.0%).

In addition, updated cost estimates related to the restructuring of our Power-to-X business result in an upward adjustment of the expected special items effect. The expected one-off restructuring cost, including impairment of Power-to-X assets is revised to 4,100–4,400 million (previous range 3,500–3,900 million) and will be primarily non-cash. The vast majority of the special items effect is expected to be recognized in 2026.

The 2026 half-year statement will be released on 27 August 2026.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Topsoe. (2026, August 28). Topsoe Updates Financial Outlook for 2026. AZoCleantech. Retrieved on August 28, 2026 from https://www.azocleantech.com/news.aspx?newsID=36564.

  • MLA

    Topsoe. "Topsoe Updates Financial Outlook for 2026". AZoCleantech. 28 August 2026. <https://www.azocleantech.com/news.aspx?newsID=36564>.

  • Chicago

    Topsoe. "Topsoe Updates Financial Outlook for 2026". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=36564. (accessed August 28, 2026).

  • Harvard

    Topsoe. 2026. Topsoe Updates Financial Outlook for 2026. AZoCleantech, viewed 28 August 2026, https://www.azocleantech.com/news.aspx?newsID=36564.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.